Apogee Therapeutics Operating Income

Apogee Therapeutics (APGE) currently reports a operating income of $-330M as of June 2026. That compares with $-270M in the prior-year period — down 21.2% year over year. Use the charts on this page to explore Apogee Therapeutics's operating income history and peer comparisons.

Apogee Therapeutics's operating income decreased from $-270M to $-330M — a 21.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Apogee Therapeutics reported $-330M in operating income as of June 2026. That compares with $-270M in the prior-year period — down 21.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-330M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apogee Therapeutics, and consider following APGE for alerts when major investors trade the stock.